Technical Specifications of Pediatric Ambulatory Care Sensitive Condition Hospitalizations

Similar documents
ICD-10-CM Coding Basics Chapter Specifics

APPENDIX A Certification of Advanced Disease:

Solid Organ Transplant Benefits to Change for Texas Medicaid

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Childhood Immunization Status (NQF 0038)

Childhood Immunization Status (NQF 0038)

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead

Cognitive enhancers for the treatment of Alzheimer s disease

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Child s Name: Date of Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT

Measure Information Form

ICD-10-CM Coding Basics Chapter Specifics

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

Nonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer

ACRIN 6666 Screening Breast US Follow-up Assessment Form

Influenza (Flu) Fact Sheet

LTCH QUALITY REPORTING PROGRAM

Request for Prior Authorization for Click here to enter text. Website Form Submit request via: Fax

2017 CMS Web Interface

Extrapulmonary Respiratory Problems. During the First Week of Life

BANKMED MEDICAL SCHEME. MEDICINE ADVISORY SERVICES (Chronic Medicine Benefit) GENERAL INFORMATION

MEASURE #10: PLAN OF CARE FOR MIGRAINE OR CERVICOGENIC HEADACHE DEVELOPED OR REVIEWED Headache

Επείγοντα καρδιολογικά προβλήματα- Διαγνωστικές και θεραπευτικές προκλήσεις Οξεία περικαρδίτιδα

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

High Performance Network Quality Criteria for Designation

Michigan Primary Care Transformation Project Performance Incentive Technical Manual

2013 DATA COLLECTION GUIDE Summary Data Submission. Optimal Asthma Care. (07/01/2012 to 06/30/2013 Dates of Service)

Kentucky Medically Frail Medical Condition Guide v5 for Providers Supplement to the Kentucky Medically Frail Provider Attestation Form

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC)

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Medical Student Immunization Requirements

2017 CMS Web Interface

This information shows what new challenges are likely to require prevention efforts moving forward.

ITP typically presents with the sudden appearance of a petechial rash, spontaneous bruising and/or bleeding in an otherwise well child.

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

Episodes of Care Risk Adjustment

Diabetes: HbA1c Poor Control (NQF 0059)

Oral Surgery (Facial Pain) Service Specification

Isle of Wight Joint Strategic Needs Assessment: Core Dataset 2009

2018 CMS Web Interface

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

2018 CMS Web Interface

NPCR CLINICAL EDIT CHECKS

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

Annex III. Amendments to relevant sections of the Product Information

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Risk factors in health and disease

2017 CMS Web Interface

Υποτροπιάζουσες Περικαρδίτιδες: Τι νεότερο; Γεώργιος Λάζαρος Επιμελητής Α Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Γ.Ν.

2018 CMS Web Interface

Consensus Recommendations for the Management of Chronic Lymphocytic Leukemia: Primary Care Guideline

Significance of Chronic Kidney Disease in 2015

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

CARDIOLOGY Referral Guidance Sheet

Important Information

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

NQF 0075 Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control

Medicare Advantage 2019 Advance Notice Part 1 21 st Century Cures Act Methodological Changes

Vaccine Information Statement: LIVE INTRANASAL INFLUENZA VACCINE

Ontario 2018 provincial election issues backgrounder

This table cannot be relied upon in the absence of: PA Medical Directive #8 - Gastroenterology

Policy Guidelines: Genetic Testing for Carrier Screening and Reproductive Planning

APPENDIX A. Comparability Ratios for the Major Causes of Death in North Carolina Vital Statistics, Volume 2

Field Epidemiology Training Program

WARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES

Community Health Worker / Certified Recovery Specialist Training Application

8. Preparation of an electronic atlas of amenable mortality (Results of work package 7)

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y

CDC Influenza Division Key Points MMWR Updates February 20, 2014

Generic Immunosuppressants in the Specialist Area of Transplantation Consensus on Implications and Practical Recommendations

MANITOBA HEALTH, HEALTHY LIVING & SENIORS WEEKLY WEST NILE VIRUS SURVEILLANCE REPORT (WEEK 27)

2018 CMS Web Interface

PART III: CONSUMER INFORMATION

Guideline Number: NIA_CG_301 Last Revised Date: October 2014 Responsible Department: Implementation Date: October 2014 Clinical Operations

IC REPORTABLE COMMUNICABLE DISEASES IN BC Rev. Jan 2017

Drug Class Review: Long-acting muscarinic antagonists (LAMAs) for treatment of chronic obstructive pulmonary disease (COPD)

Randolph-Macon College Student Health Center P.O. Box 5005 Ashland, VA Phone:

Cardiac Rehabilitation Services

Package leaflet: Information for the user. GASTROGRAFIN GASTROENTERAL SOLUTION Sodium amidotrizoate and meglumine amidotrizoate

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Folotyn (pralatrexate)

Patient Name: Address City State Zip Code. H. Phone W. Phone Cell Phone. Occupation Employer

Assessment, History and Physical. Renal Ultrasound

Erythropoiesis Stimulating Agents (ESAs): Aranesp (darbepoetin alfa) Related Medical Guideline Off-Label Use of FDA-Approved Drugs and Biologicals

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

Printed copies of this document may not be up to date, obtain the most recent version from Author Position

ASCR REPORTABLE LIST (2016)

The research question: What was discovered in the 1940s that could treat syphilis?

2017 CMS Web Interface

Name: Date: Period: Notes: The Blood and Lymphatic System

Please list any other health concerns (physical, emotional or mental) in order of importance:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

2017 CMS Web Interface

Transcription:

Technical Specificatins f Pediatric Ambulatry Care Sensitive Cnditin Hspitalizatins Surce: The Canadian Institute fr Health Infrmatin Database(s): Discharge Abstract Database (DAD) Level(s) f Care (facility type): Acute Care (excluding Quebec) Fiscal Year(s): 2014/15 and 2015/16 (cmbined) Scpe: All acute paediatric inpatient recrds, including deaths submitted t the DAD fr fiscal years 2014/15 and 2015/16. Grupings: Neighburhd Incme Quintile f patient pstal cde Cases frm the Yukn, Nrthwest Territries and Nunavut will be gruped, due t the lw number f facilities in these prvinces / territries. 1. ASTHMA Numeratr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 2-17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde f Asthma (J45.-) Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn AND Patients with any f the fllwing diagnsis cdes (in any diagnsis cde lcatin) n the abstract: E84.^ - Cystic fibrsis J98.4 - Other disrders f the lung P27.^ - Chrnic respiratry disease rig. in the perinatal perid P28.^ - Other respiratry disease rig. in the perinatal perid Q30-Q34 - Cngenital malfrmatins f the respiratry system Q25.4 - Other cngenital malfrmatin f arta Q39.3 - Cngenital stensis and stricture f esphagus

2 Q39.4 - Oesphageal web Q89.3 - Situs inversus Denminatr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 2-17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde = any diagnsis cde Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn Include all acute hspitalizatins where the MRDx is the indicatr f interest, including multiple ccurrences within the tw (2) year study perid. Include all recrds fr the receiving Acute Care facilities where the patient was transferred frm an Emergency Department t the receiving Acute Care facility and the MRDx is the indicatr f interest. Exclude all recrds fr the receiving Acute Care facilities where the patient was transferred frm ne (1) Acute Care facility t the receiving Acute Care facility and the MRDx is the indicatr f interest. 2. DIABETES SHORT TERM COMPLICATIONS Numeratr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 6-17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde f Diabetes: E10.0 - Type 1 diabetes mellitus with cma E11.0 - Type 2 diabetes mellitus with cma E13.0 - Other specified diabetes mellitus with cma E14.0 - Unspecified diabetes mellitus with cma E10.10 - Type 1 diabetes mellitus with ketacidsis E11.10 - Type 2 diabetes mellitus with ketacidsis E13.10 - Other specified diabetes mellitus with ketacidsis E14.10 - Unspecified diabetes mellitus with ketacidsis E10.11 - Type 1 diabetes mellitus with lactic acidsis E11.11 - Type 2 diabetes mellitus with lactic acidsis

3 E13.11 - Other specified diabetes mellitus with lactic acidsis E14.11 - Unspecified diabetes mellitus with lactic acidsis E10.12 - Type 1 diabetes mellitus with ketacidsis with lactic acidsis E11.12 - Type 2 diabetes mellitus with ketacidsis with lactic acidsis E13.12 - Other specified diabetes mellitus with ketacidsis with lactic acidsis E14.12 - Unspecified diabetes mellitus with ketacidsis with lactic acidsis E10.64 - Type 1 diabetes mellitus with pr cntrl, s described E11.64 - Type 2 diabetes mellitus with pr cntrl, s described E13.64 - Other specified diabetes mellitus with pr cntrl, s described E14.64 - Unspecified diabetes mellitus with pr cntrl, s described Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn Denminatr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 6-17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde = any diagnsis cde Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn Include all acute hspitalizatins where the MRDx is the indicatr f interest, including multiple ccurrences within the tw (2) year study perid. Include all recrds fr the receiving Acute Care facilities where the patient was transferred frm an Emergency Department t the receiving Acute Care facility and the MRDx is the indicatr f interest. Exclude all recrds fr the receiving Acute Care facilities where the patient was transferred frm ne (1) Acute Care facility t the receiving Acute Care facility and the MRDx is the indicatr f interest.

4 3. PERFORATED APPENDIX ADMISSIONS Numeratr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 1-17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde f Acute Appendicitis with Peritnitis: K35.2 - Acute appendicitis with generalized peritnitis K35.3 - Acute appendicitis with lcalized peritnitis Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn Denminatr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 1-17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde f Appendicitis: K35.2 - Acute appendicitis with generalized peritnitis K35.3 Acute appendicitis with lcalized peritnitis K35.8 Acute appendicitis, ther and unspecified K36 - Other appendicitis K37 - Unspecified appendicitis Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn If a patient has multiple hspital admissins with an MRDx f appendicitis r is transferred t anther acute facility with an MRDx f appendicitis, nly include the first ccurrence, fr that patient, fr that specific indicatr in the numeratr/denminatr. The patient will nly be cunted nce fr this indicatr.

5 4. DEHYDRATION AND GASTROENTERITIS (COMBINED) Numeratr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 3 mnths -17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde f Gastrenteritis: A08.^ - Viral and ther specified intestinal infectins A09.^ - Other gastrenteritis and clitis f infectius and unspecified rigin K52.9 - Nninfective gastrenteritis and clitis, unspecified K52.8 - Other specified nninfective gastrenteritis and clitis OR Cmbinatin cding f a Mst Respnsible Diagnsis (MRDx) cde f Dehydratin: E86.^ - Vlume depletin P74.1 - Dehydratin f newbrn AND Gastrenteritis cde with a diagnsis type f 1, 2, W, X, r Y: A08.^ - Viral and ther specified intestinal infectins A09.^ - Other gastrenteritis and clitis f infectius and unspecified rigin K52.9 - Nninfective gastrenteritis and clitis, unspecified K52.8 - Other specified nninfective gastrenteritis and clitis Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn AND Patients with any f the fllwing diagnsis cdes (in any diagnsis cde lcatin) n the abstract: Bacterial r ther gastrenteritis A02.^ - Other salmnella infectins A03.^ - Shigellsis A04.^ - Other bacterial intestinal infectins A05.^ - Other bacterial fdbrne intxicatins, nt elsewhere classified A06.^ - Amebiasis A07.^ - Other prtzal intestinal diseases B37.81 - Candidal enteritis Gastrintestinal abnrmalities K50.^ - Crhn's disease [reginal enteritis] K51.^ - Ulcerative clitis K52.0 - Gastrenteritis and clitis due t radiatin K52.1 - Txic gastrenteritis and clitis K52.2 - Allergic and dietetic gastrenteritis and clitis K52.3 - Indeterminate clitis

6 K90.^ - Intestinal malabsrptin K91.2 - Pstsurgical malabsrptin, nt elsewhere classified K92.80 - Mucsitis (ulcerative) f the digestive system Denminatr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 3 mnths - 17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde = any diagnsis cde Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn Include all acute hspitalizatins where the MRDx is the indicatr f interest, including multiple ccurrences within the tw (2) year study perid. Include all recrds fr the receiving Acute Care facilities where the patient was transferred frm an Emergency Department t the receiving Acute Care facility and the MRDx is the indicatr f interest. Exclude all recrds fr the receiving Acute Care facilities where the patient was transferred frm ne (1) Acute Care facility t the receiving Acute Care facility and the MRDx is the indicatr f interest. 5. URINARY TRACT INFECTION Numeratr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 3 mnths -17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde f Urinary Tract Infectin: N10 - Acute tubule-interstitial nephritis N15.1 - Renal and perinephric abscess N30.0 - Acute cystitis N39.0 - Urinary tract infectin, site nt specified N15.9 - Renal tubule-interstitial disease, unspecified N12 -Tubul-interstitial nephritis, nt specified as acute r chrnic N28.83 - Pyelitis cystica N28.84 - Pyelureteritis cystica

7 N28.85 - Ureteritis cystica Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn AND Patients with any f the fllwing diagnsis cdes (in any diagnsis cde lcatin) n the abstract: Immuncmprmised B24 - Human immundeficiency virus [HIV] disease B59 - Pneumcystsis (J17.3*) C81-C96 - Malignant neplasms f lymphid, haematpietic and related tissue D47.^ - Other neplasms f uncertain r unknwn behaviur f lymphid, haematpietic and related tissue D57.^ - Sickle-cell disrders D61.^ - Other aplastic anaemias D80.^ - Immundeficiency with predminantly antibdy defects D81.^ - Cmbined immundeficiencies D82.^ - Immundeficiency assciated with ther majr defects D83.^ - Cmmn variable immundeficiency D84.^ - Other immundeficiencies D89.^ - Other disrders invlving the immune mechanism, nt elsewhere classified T86.^ - Failure and rejectin f transplanted rgans and tissues Z94.^ - Transplanted rgan and tissue status B18.^ - Chrnic viral hepatitis D73.0 - Hypsplenism D73.1 - Hypersplenism Q89.0 - Cngenital malfrmatins f spleen D73.2 - Chrnic cngestive splenmegaly D73.3 - Abscess f spleen Kidney/urinary tract abnrmalities N11.^ - Chrnic tubul-interstitial nephritis N13.^ - Obstructive and reflux urpathy N14.^ - Drug- and heavy-metal-induced tubul-interstitial and tubular cnditins N15.0 - Balkan nephrpathy N15.8 - Other specified renal tubule-interstitial diseases N16.^ - Renal tubul-interstitial disrders in diseases classified elsewhere N17.^ - Acute renal failure N18.^ - Chrnic kidney disease N19 - Unspecified kidney failure N20-N23 - Urlithiasis N25-N29 - Other disrders f kidney and ureter N30.1 - Interstitial cystitis (chrnic) N30.2 - Other chrnic cystitis N30.3 - Trignitis N30.4 - Irradiatin cystitis N30.8 - Other cystitis- includes abscess f bladder/cystitis cystic glandularis

8 N30.9 - Cystitis, unspecified N31.^ - Neurmuscular dysfunctin f bladder, nt elsewhere classified N32.0 - Bladder-neck bstructin N33.0 - Tuberculsis cystitis N33.8 - Bladder disrders in ther diseases classified elsewhere N34.^ - Urethritis and urethral syndrme N35.^ - Urethral stricture N36.^ - Other disrders f urethra N37.^ - Urethral disrders in diseases classified elsewhere N39.1 - Persistent prteinuria, unspecified N39.8 - Other specified disrders f urinary system N06.^ - Islated prteinuria with specified mrphlgical lesin Q60-Q64 - Cngenital malfrmatins f the urinary system E1*.23 + N08.3^ - Diabetes Mellitus with ESRD Denminatr: Inclusins: Analytical Institutin Type = Acute Inpatient AND Submitting Prvince/Territry = All (excluding Quebec) AND Patients age 3 mnths - 17 (inclusive, including deaths) years ld nly AND Canadian residents nly (include hmeless and unknwn) AND Mst Respnsible Diagnsis (MRDx) cde = any diagnsis cde Exclusins: Newbrns, Stillbirths, and Cadaveric Dnatins AND Obstetrical recrds with the fllwing diagnsis cdes in any psitin: O00 O99 (inclusive) - Pregnancy, Childbirth and the Puerperium Z37.^ - Outcme f Delivery A34 - Obstetrical Tetanus P96.4 - Terminatin f pregnancy, affecting fetus and newbrn Include all acute hspitalizatins where the MRDx is the indicatr f interest, including multiple ccurrences within the tw (2) year study perid. Include all recrds fr the receiving Acute Care facilities where the patient was transferred frm an Emergency Department t the receiving Acute Care facility and the MRDx is the indicatr f interest. Exclude all recrds fr the receiving Acute Care facilities where the patient was transferred frm ne (1) Acute Care facility t the receiving Acute Care facility and the MRDx is the indicatr f interest.